Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Morelli

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Cell Reports|August 31, 2017
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and FunctionFederica F Morelli, Dineke S Verbeek, Jessika Bertacchini, et al.
Expert Review of Clinical Pharmacology|January 21, 2021
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trialA Mennitto, E Verzoni, F Cognetti, et al.
Cardiovascular and Interventional Radiology|January 9, 2025
Safety and Efficacy of Portal Vein Recanalization with Creation of Intrahepatic Portosystemic Shunt (PVR-TIPS) to Treat Chronic Portal Vein Thrombosis in Non-cirrhotic PatientsF Barbosa, P Aseni, M Vertemati, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialM Bachner, Y Loriot, M Gross-Goupil, et al.
Cell Death & Disease|May 7, 2021
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptorTatiana Tiago, Barbara Hummel, Federica F Morelli, et al.
Nature Communications|December 19, 2018
Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networksMelanie Meister-Broekema, Rebecca Freilich, Chandhuru Jagadeesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trialM G Ghi, A Paccagnella, D Ferrari, et al.
Nature Medicine|October 16, 2025
Characterizing the physiology of circulatory arrest in humansJordan D Bird, Laura Hornby, Veronica Hirsch-Reinshagen, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Cell Reports|August 31, 2017
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and FunctionFederica F Morelli, Dineke S Verbeek, Jessika Bertacchini, et al.
Expert Review of Clinical Pharmacology|January 21, 2021
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trialA Mennitto, E Verzoni, F Cognetti, et al.
Cardiovascular and Interventional Radiology|January 9, 2025
Safety and Efficacy of Portal Vein Recanalization with Creation of Intrahepatic Portosystemic Shunt (PVR-TIPS) to Treat Chronic Portal Vein Thrombosis in Non-cirrhotic PatientsF Barbosa, P Aseni, M Vertemati, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
ESMO Open|May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohortG Fornarini, S E Rebuzzi, G L Banna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2011
2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialM Bachner, Y Loriot, M Gross-Goupil, et al.
Cell Death & Disease|May 7, 2021
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptorTatiana Tiago, Barbara Hummel, Federica F Morelli, et al.
Nature Communications|December 19, 2018
Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networksMelanie Meister-Broekema, Rebecca Freilich, Chandhuru Jagadeesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trialM G Ghi, A Paccagnella, D Ferrari, et al.
Nature Medicine|October 16, 2025
Characterizing the physiology of circulatory arrest in humansJordan D Bird, Laura Hornby, Veronica Hirsch-Reinshagen, et al.
Pageof 12